Live Breaking News & Updates on Mini Symposium Session
Stay updated with breaking news from Mini symposium session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & SAN MATEO, Calif. & STAMFORD, Conn. (BUSINESS WIRE) MapKure, LLC, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), today announced that they will present updated clinical data from the Phase 1a/1b study of B. ....
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & STAMFORD, Conn. (BUSINESS WIRE) BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), and SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), today announced that they will present updated clinical data from the Phase 1b trial of BeiGene’s RAF dimer inhibitor, lifiraf. ....
MapKure, LLC, BeiGene, Ltd. , and SpringWorks Therapeutics, Inc. , today announced that they will present updated clinical data from the Phase 1a/1b study of BGB-3245, an investigational, selective. | April 17, 2023 ....
BeiGene, Ltd. , and SpringWorks Therapeutics, Inc. , today announced that they will present updated clinical data from the Phase 1b trial of BeiGene’s RAF dimer inhibitor, lifirafenib, in. | April 17, 2023 ....
STAMFORD, Conn. and BASEL, Switzerland and BEIJING and CAMBRIDGE, Mass. and SAN MATEO, Calif., April 17, 2023 MapKure, LLC, SpringWorks Therapeutics, Inc. , and BeiGene, Ltd. , today. | April 17, 2023 ....